ABEO financials
Abeona Therapeutics (ABEO) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ABEO income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $5.82M | $4.29M | -$89.45M | $71.18M | 1.01 |
| 2024 | – | – | -$64.21M | -$63.73M | -1.55 |
| 2023 | $3.50M | – | -$47.13M | -$54.20M | -2.53 |
| 2022 | $1.41M | – | -$50.91M | -$43.48M | -5.53 |
| 2021 | $3.00M | – | -$89.84M | -$84.94M | -21.57 |
| 2020 | $10.00M | – | -$81.42M | -$84.23M | -22.75 |
- ABEO revenue was $5.82M in fiscal 2025, net income $71.18M.
Updated 2026-11-09 19:47 UTC